Posts tagged Artificial intelligence
BenevolentAI Awarded Technology Pioneer Status by World Economic Forum

Every year, the World Economic Forum welcomes leading early-stage technology companies from around the world into its Technology Pioneer’s community. In its own words, these companies are “poised to have a significant impact on business and society”. Today we are delighted and humbled to be named as one such Technology Pioneer.

Read More
BenevolentAI raises $115 million to extend its leading global position in the field of AI enabled drug development

BenevolentAI raises $115 million, now valued at $2 billion. Funds raised to significantly scale BenevolentAI drug development activities, broaden the disease areas on which it focuses, and extend its AI platform capabilities

Read More
BenevolentAI acquires advanced Cambridge research facility to accelerate its AI-enabled drug development

BenevolentAI acquires clinical development research facility in Cambridge to drive AI drug discovery. Acquisition creates first AI company capable of covering entire drug development process from drug discovery to clinical development.

Read More